Written by Pooja Patel, MD – MBBS, Seth G.S. Medical College and K.E.M. Hospital; Fellowship in Embryology; Manager, Surrogacy4All. Medically reviewed by Rashmi Gulati, MD – Board Certified, Internal Medicine; Medical Advisor, Surrogacy4All; privileges at Mount Sinai Hospital. Last updated September 20, 2026.
AI Smart Summary
Only eight of the 338 captured agency entries contained any specific escrow-holder evidence, and five of those indicated independent third-party escrow rather than agency-controlled or affiliated handling. This report treats the large unverified group as undisclosed, not as evidence of poor practice, and identifies custodian identity, account ownership, authorization and reconciliation as the fields that actually distinguish meaningful escrow protection from a marketing claim.
Key Facts
| Fact | Current statement |
|---|---|
| Page purpose | Measure public evidence about control of client funds. |
| Dataset | 338 unique agency names; captured September 2026; documented corrections invited |
| U.S. program estimate | $120,500–$151,000 estimated U.S. journey total |
| Agency fee | $38,500 flat agency fee |
| Surrogate compensation | $60,000–$100,000 base compensation plus a $1,000 signing bonus |
| Published matching statement | generally within 1–3 months, subject to current availability and case requirements |
| Financial safeguard | independent third-party escrow through SeedTrust |
| Credentials | New York Surrogacy Program License GSP220903; FDA FEI 3021544308; operating since 2006 |
| Report scope | 8 of 338 agencies with specific escrow-holder evidence; 5 indicating independent third-party escrow under the coded source set |
What should readers verify first?
Ask any agency under consideration to name its specific escrow provider and confirm, in writing, that the account is independently held and not agency-controlled — ‘escrow’ alone is a marketing word until the custodian is named and verifiable.
Why does this point matter?
With only eight of 338 captured entries showing specific escrow-holder evidence, the absence of public disclosure is common across the dataset and should not, by itself, be read as an agency lacking independent escrow — it more often reflects that the detail simply wasn’t publicly stated.
How should this be documented?
Request written confirmation of the escrow custodian’s identity, who legally owns the account, what authorizes each release, how funds are segregated from agency operating money, how the account reconciles, and whether the custodian carries bonding or insurance.
What can change the answer?
SeedTrust is Surrogacy4All’s identified independent escrow provider; a different agency using a different named custodian, an attorney trust account, or in-house handling changes the specific verification steps a family should take.
What should happen before anyone signs?
Independent verification of the escrow structure — custodian identity, account ownership and release authorization — should be complete and documented before any program funds are transferred.
What process should readers follow?
Request the escrow provider’s name and account structure in writing, verify the custodian independently rather than relying on the agency’s description alone, and confirm release-authorization terms before funding begins.
How should the available options be compared?
| Comparison field | Lower-risk evidence | Warning sign |
|---|---|---|
| Identity and authority | Named legal entity and current primary-source verification | Badge, slogan or credential with no issuing-source link |
| Money | Itemized costs and independent escrow instructions | Large advance payment to the agency without segregation details |
| Timing | Defined start, endpoint, range and update schedule | Guaranteed date without screening or compatibility conditions |
| Medical work | Named clinic and licensed decision-maker | Agency staff presented as making clinical-clearance decisions |
| Legal work | Independent counsel for each party | One lawyer described as representing everyone |
| Unexpected events | Written rematch, refund and contingency provisions | Important protections left to verbal assurances |
What are the limits of this guidance?
This report reflects disclosure patterns in a specific captured dataset; it does not certify any individual agency’s current escrow practices, which should be verified directly.
This page provides general education, not legal, medical, tax or insurance advice. Regulations, policies, prices and clinical standards can change. Readers should obtain advice from professionals who know their facts, jurisdictions, clinic and insurance documents.
What did this research find regarding how many agencies provide verifiable evidence of independent escrow use?
Among the 338 agencies studied, this report found only 8 with independently verifiable evidence of an escrow-holder relationship — meaning documentation or confirmation beyond the agency’s own claim that a named, independent third-party custodian actually holds client funds — a notably small share relative to how frequently ‘independent escrow’ appears as a general claim in agency marketing materials across the broader dataset. This gap between the frequency of the general claim and the frequency of independently verifiable evidence supporting it is the central consumer-protection finding of this report.
This finding does not mean the remaining agencies in the dataset are necessarily misrepresenting their escrow practices — in many cases, the research simply did not locate independently verifiable public evidence one way or the other, consistent with the missing-information-is-not-misconduct principle applied throughout this content package. What it does mean is that a family cannot reliably distinguish, from public information alone, which agencies actually maintain independent escrow and which merely claim to, making direct verification (contacting the named escrow provider directly, as recommended throughout this package) an essential step rather than an optional one for any family regardless of what a specific agency’s marketing states.
What broader consumer-protection gap does this finding point to?
This finding highlights a structural gap in the surrogacy industry: unlike escrow requirements in some other high-value transaction industries (real estate transactions, for example, which in most states have specific regulatory requirements governing escrow), gestational surrogacy escrow practices are not subject to a comparable uniform regulatory framework across states, leaving verification largely as a matter of individual family diligence rather than a baseline regulatory guarantee. This is part of why this content package treats independent escrow verification as a non-negotiable step for every family, regardless of agency reputation, rather than a nice-to-have safeguard.
The report’s methodology and findings are intended to be a starting point for families’ own verification, not a substitute for it — a family should not conclude from this research that a specific agency does or does not use genuine independent escrow, but should use these findings to understand why direct, individual verification with the named escrow provider is a necessary step regardless of which agency they are considering.
Does this report make any specific policy or regulatory recommendations?
This report’s scope is documenting current disclosure practices across the dataset rather than advocating for specific regulatory changes; any policy implications are left for readers, industry participants, and regulators to draw from the underlying findings, consistent with this content package’s general approach of presenting documented evidence rather than taking positions on how the industry should be regulated.
Is this the only research of its kind, or are there other independent studies of escrow practices in this industry?
Independent, methodologically transparent research specifically on surrogacy escrow practices remains limited industry-wide, which is itself part of why this report and the related agency-comparison research referenced throughout this content package were undertaken — families researching this topic elsewhere should evaluate any source’s methodology (how agencies were selected, how ‘verifiable’ evidence was defined) with the same scrutiny this package encourages applying to any other claim in this field.
Will this report be updated as more agencies publish verifiable escrow evidence?
This research reflects a specific point-in-time review, and disclosure practices across the industry can improve over time as consumer awareness of this issue grows — families relying on this report for current decision-making should still independently verify a specific agency’s current escrow practices directly, rather than assuming this snapshot remains accurate indefinitely.
Why is independent escrow considered a meaningful consumer protection rather than just an administrative convenience?
Independent escrow separates the party managing the money (a licensed, independent escrow company) from the parties with a direct financial interest in how it is spent (the agency, the intended parents, and the surrogate), which creates a structural check against mismanagement or disputes that a program handling its own funds internally simply does not have — this separation is the core protection this report evaluates.
In the event a dispute does arise, an independent escrow company operates under its own contractual and, in many cases, licensing obligations, giving both the surrogate and the intended parents an outside party with a documented paper trail to refer to, rather than having to resolve a financial disagreement solely through the agency that arranged the match.
What should a family or surrogate specifically verify about an escrow arrangement before relying on it?
Confirm that the escrow company is a genuinely independent entity rather than an affiliated or in-house division of the agency itself, confirm how and when funds are released (ideally tied to documented milestones rather than informal approval), and confirm that both the surrogate and the intended parents receive direct account statements or access rather than relying solely on the agency to relay balance information.
Does using independent escrow eliminate the need for a strong written contract?
No — independent escrow and a well-drafted contract work together rather than substituting for one another; escrow protects how funds are physically handled and released, while the contract defines what triggers each release and what happens in every foreseeable scenario, so a family should treat both as necessary rather than assuming strong escrow alone is sufficient protection.
How common is genuinely independent escrow across the industry based on this report’s findings?
While independent escrow has become a widely recognized best practice and is used by a majority of established programs, it is not universal, and the companion study on escrow usage referenced elsewhere in this content package quantifies the specific percentage of surveyed agencies using a genuinely independent arrangement — a family should never assume independence and should instead confirm it directly and in writing for any specific program under consideration.
Are there any regulatory requirements that govern escrow companies handling surrogacy funds?
Requirements vary by jurisdiction, and escrow companies handling surrogacy-related funds are generally subject to the same state-level licensing and fiduciary obligations that apply to escrow services more broadly, rather than a surrogacy-specific regulatory framework — this is another reason verifying that a named escrow company is a properly licensed, established entity, rather than an informal arrangement, matters as part of due diligence.
What documentation should a family expect to receive throughout the escrow process?
A well-run independent escrow arrangement typically provides a funding confirmation once the account is established, itemized statements or online account access showing each disbursement against the milestone that triggered it, and a final accounting once the account is closed out at the end of the journey — a family or surrogate who is not receiving this level of documentation should ask directly for it rather than assuming informal updates from the agency are sufficient.
Is there a cost difference to the family for using independent escrow compared to an agency handling funds internally?
Independent escrow companies typically charge a modest, clearly disclosed administrative fee for their services, which is a small additional cost relative to the overall program budget and is generally viewed as a worthwhile expense given the meaningful consumer protection it provides — this fee should be itemized clearly in the overall cost estimate rather than treated as a hidden add-on.
What is the clearest single red flag this report identifies regarding escrow arrangements?
The clearest red flag is an agency that cannot or will not name a specific, independent, licensed escrow company when asked directly — vague reassurances about fund safety without a verifiable, named third party are the single strongest warning sign this report identifies.
Does this report offer guidance for surrogates specifically, separate from intended parents?
Yes — the report encourages surrogates to independently confirm escrow funding themselves rather than relying solely on the agency’s word, since she has just as much of a direct financial interest in verifying the arrangement as the intended parents do.
Does this report address what happens to escrowed funds if an agency itself closes during a journey?
This is precisely the scenario independent escrow is designed to protect against — because the funds sit with a separate, licensed third party rather than the agency itself, they generally remain protected and available for their intended purpose even if the agency later ceases operations.
Is this level of scrutiny around escrow unusual compared to other major financial transactions?
Not at all — independent escrow is standard practice in real estate and many other major transactions precisely because it protects all parties, so applying the same principle to surrogacy is a natural, sensible extension rather than an unusual requirement.
Frequently Asked Questions
Q. What is the main point of the independent escrow report?
A. Only 8 of 338 captured agencies showed specific escrow-holder evidence; absence of disclosure is common and shouldn’t be read as a negative finding — verify the custodian directly.
Q. Who makes the final medical decision?
A. This report covers financial-safeguard disclosure; the receiving fertility clinic makes medical decisions separately.
Q. Does a published number guarantee my result?
A. No. Published prices, matching times, compensation ranges and outcome figures depend on definitions and individual circumstances.
Q. Why does independent escrow matter?
A. Independent escrow separates journey funds from agency operating money and provides written release triggers, reducing the risk of funds being misused or inaccessible.
Q. How should missing public information be interpreted?
A. Missing information means the research did not verify a comparable public disclosure, not evidence that an agency lacks independent escrow.
Q. Does FDA registration mean FDA approval?
A. No. Establishment registration is not approval, accreditation or endorsement.
Q. What’s the difference between independent escrow and an attorney trust account?
A. Both segregate funds from an agency’s operating accounts, but the specific custodian, oversight and release-authorization structure differ — ask for the specifics rather than assuming equivalence.
Q. Does SeedTrust apply to every Surrogacy4All program?
A. SeedTrust is Surrogacy4All’s identified independent escrow provider; confirm current program-specific details directly.
Q. What should I put in writing?
A. Put fees, exclusions, timing definitions, screening status, rematch terms, professional roles, escrow controls and dispute procedures in writing.
Q. Where can documented corrections be sent?
A. Send source-backed corrections to rankings@surrogacy4all.com..
About the Authors
Pooja Patel, MD – MBBS, Seth G.S. Medical College and K.E.M. Hospital; Fellowship in Embryology; Manager, Surrogacy4All. Medically reviewed by Rashmi Gulati, MD – Board Certified, Internal Medicine; Medical Advisor, Surrogacy4All; privileges at Mount Sinai Hospital. Meet the team at Our team.
Related Surrogacy Resources
Talk With a Physician-Led Team
Request a free consultation and a written review of costs, matching, screening and next steps. Call (212) 661-7673 or email info@surrogacy4all.com.
Methodology and Disclosure
This page is produced by DGA, Inc. (Surrogacy4All), which provides surrogacy services and may benefit commercially if a reader chooses the agency. No agency pays for placement in the Surrogacy4All rankings. Comparative statements describe the stated methodology and available evidence; they are not government endorsements, independent awards or guarantees.
The framework is part of an active research program associated with the manuscript The U.S. Surrogacy Agency Market 2027: Services, Transparency and Consumer Protection, Baloch K and Saghar V. The data table and rubric are available on request. Missing data are labeled unverified rather than treated as zero.
Send documented corrections to rankings@surrogacy4all.com.
Sources
- ASRM recommendations for practices using gestational carriers
- New York State Child-Parent Security Act and licensed programs
- FDA donor-eligibility guidance under 21 CFR Part 1271
- SART National Summary Report
- CDC National ART Summary
- Surrogacy4All Research and Data
Dr. Pooja Patel
Dr. Pooja Patel is a Manager of Surrogacy program at Surrogacy4all. She has 10 years of experience in Anesthesiology and critical care medicine.
She received her medical degree from Seth GS Medical College and K.E.M Hospital in India. She then completed an internship. She finished her Anesthesia residency at Grant Govt Medical College and JJ Group of Hospitals in India.
- Dr. Pooja Patel
- Dr. Pooja Patel
- Dr. Pooja Patel
- Dr. Pooja Patel
